Korea’s film industry is leaning heavily on scale and star power in its 2026 release slate, according to trade coverage previewing the year’s lineup, as the domestic box office continues working to recover from a prolonged post-pandemic slump that has left annual admissions well below pre-2020 levels.
The Korea Film Council’s own preview of the year’s slate frames 2026 as a test of whether Korean cinema can “break through the slump” with a run of high-profile releases spanning genres, from Na Hong-jin’s record-budget science-fiction horror “Hope” to major studio dramas and franchise sequels aimed at drawing older, previously reliable moviegoing audiences back into theaters after years of habit shifting toward streaming.
The industry’s challenge is structural as much as creative: Korean audiences, like moviegoers globally, shifted significant viewing time to streaming platforms during pandemic-era theater closures, and theatrical attendance in Korea, as in many markets, has not fully rebounded even as theaters have long since reopened and streaming restrictions have lifted. That has forced studios toward a strategy of concentrating investment in a smaller number of event-scale releases capable of drawing audiences back to cinemas specifically, rather than spreading budgets across a larger volume of mid-budget productions.
Whether the strategy succeeds will become clearer as the year’s tentpole releases reach theaters, but the scale of investment in 2026’s slate suggests Korean studios are betting that spectacle and star power, rather than smaller, more numerous releases, offer the clearer path back to pre-pandemic box office health.
Source: Korean Film Council (KOFIC) webzine, “Can Korean Cinema Leap Back After the Slump? The 2026 Lineup,” 2026.
